GPX4 mRNA expression was substantially associated with the prognosis of COAD, Glioma, Liver hepatocellular carcinoma, and other cancers, as determined using the Sangerbox database (Fig. S1A). The gene discussed is GPX4; the disease is central nervous system cancer.